Supplementary Table 2.docx (12.58 kB)
Download fileSupplementary Table 2: DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain.
dataset
posted on 2021-05-06, 09:20 authored by Cristobal Morales, Virginia Bellido, Cristina Tejera, Fernando Goñi, Rafael Palomares, Cristina Sevillano, Diego Bellido, Alfonso Soto, Miguel Ángel Mangas, Manuel A Botana, Irene Caballero
Supplementary Table S2. DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain.
Abstract |